3//SEC Filing
AQUILA INVESTMENTS IV 3
Accession 0001104659-19-031232
CIK 0001761612other
Filed
May 21, 8:00 PM ET
Accepted
May 22, 9:53 PM ET
Size
6.7 KB
Accession
0001104659-19-031232
Insider Transaction Report
Form 3
AQUILA INVESTMENTS IV
10% Owner
Holdings
- (indirect: By Aquila Investments IV)
Series B2 Preferred Shares
→ Ordinary Shares (1,454,411 underlying) - (indirect: By Aquila Investments IV)
Series B1 Preferred Shares Warrants
Exp: 2025-03-31→ Series B1 Preferred Shares (139,264 underlying)
Footnotes (4)
- [F1]Each Series B1 Preferred Share shall automatically convert into Ordinary Shares on a one for 1.429 basis immediately prior to the closing of the Issuer's initial public offering and have no expiration date.
- [F2]Share numbers give effect to the bonus shares issued to each holder of ordinary shares on the basis of 1.429 bonus shares for each ordinary share in issue, effective on May 13, 2019, which will be effective for the ordinary shares upon their conversion to ordinary shares upon the closing of the Issuer's initial public offering. The number of shares reflects the conversion of the Series B1 Preferred Shares and Series B2 Preferred Shares to Ordinary Shares set out in footnote (1).
- [F3]The shares are held by Aquila Investments IV, an affiliate of Tybourne Capital Management.
- [F4]The Warrants to purchase Series B2 Preferred Shares have an exercise price of a nominal value per share. The Warrants are immediately exercisable and expire on March 31, 2025.
Documents
Issuer
BICYCLE THERAPEUTICS Ltd
CIK 0001761612
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001777368
Filing Metadata
- Form type
- 3
- Filed
- May 21, 8:00 PM ET
- Accepted
- May 22, 9:53 PM ET
- Size
- 6.7 KB